Cargando…
Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV
Halophilic archaea is considered an promising natural source of many important metabolites. This study focused on one of the surface-active biomolecules named biosurfactants produced by haloarchaeon Natrialba sp. M6. The production trend was optimized and the product was partially purified and ident...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531635/ https://www.ncbi.nlm.nih.gov/pubmed/36195643 http://dx.doi.org/10.1038/s41598-022-20091-0 |
_version_ | 1784801941236219904 |
---|---|
author | Hegazy, Ghada E. Abu-Serie, Marwa M. Abou-elela, G. M. Ghozlan, Hanan Sabry, Soraya A. Soliman, Nadia A. Teleb, Mohamed Abdel-Fattah, Yasser R. |
author_facet | Hegazy, Ghada E. Abu-Serie, Marwa M. Abou-elela, G. M. Ghozlan, Hanan Sabry, Soraya A. Soliman, Nadia A. Teleb, Mohamed Abdel-Fattah, Yasser R. |
author_sort | Hegazy, Ghada E. |
collection | PubMed |
description | Halophilic archaea is considered an promising natural source of many important metabolites. This study focused on one of the surface-active biomolecules named biosurfactants produced by haloarchaeon Natrialba sp. M6. The production trend was optimized and the product was partially purified and identified using GC–Mass spectrometry. Sequential optimization approaches, Plackett–Burman (PB) and Box–Behnken Designs (BBD) were applied to maximize the biosurfactants production from M6 strain by using 14 factors; pH, NaCl, agitation and glycerol; the most significant factors that influenced the biosurfactant production were used for Response Surface Methodology (RSM). The final optimal production conditions were agitation (150 rpm), glycerol (3%), NaCl (20.8%), pH (12) and cultivation temperature (37°C). GC–Mass spectrometry for the recovered extract revealed the presence of a diverse group of bipolar nature, hydrophobic hydrocarbon chain and charged function group. The majority of these compounds are fatty acids. Based on results of GC–MS, compositional analysis content and Zetasizer, it was proposed that the extracted biosurfactant produced by haloarchaeon Natrialba sp. M6 could be a cationic lipoprotein. The antiviral activity of such biosurfactant was investigated against hepatitis C (HCV) and herpes simplex (HSV1) viruses at its maximum safe doses (20 μg/mL and 8 μg/mL, respectively). Its mode of antiviral action was declared to be primarily via deactivating viral envelopes thus preventing viral entry. Moreover, this biosurfactant inhibited RNA polymerase- and DNA polymerase-mediated viral replication at IC(50) of 2.28 and 4.39 μg/mL, respectively also. Molecular docking studies showed that surfactin resided well and was bound to the specified motif with low and accepted binding energies (ΔG = − 5.629, − 6.997 kcal/mol) respectively. Therefore, such biosurfactant could be presented as a natural safe and effective novel antiviral agent. |
format | Online Article Text |
id | pubmed-9531635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-95316352022-10-05 Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV Hegazy, Ghada E. Abu-Serie, Marwa M. Abou-elela, G. M. Ghozlan, Hanan Sabry, Soraya A. Soliman, Nadia A. Teleb, Mohamed Abdel-Fattah, Yasser R. Sci Rep Article Halophilic archaea is considered an promising natural source of many important metabolites. This study focused on one of the surface-active biomolecules named biosurfactants produced by haloarchaeon Natrialba sp. M6. The production trend was optimized and the product was partially purified and identified using GC–Mass spectrometry. Sequential optimization approaches, Plackett–Burman (PB) and Box–Behnken Designs (BBD) were applied to maximize the biosurfactants production from M6 strain by using 14 factors; pH, NaCl, agitation and glycerol; the most significant factors that influenced the biosurfactant production were used for Response Surface Methodology (RSM). The final optimal production conditions were agitation (150 rpm), glycerol (3%), NaCl (20.8%), pH (12) and cultivation temperature (37°C). GC–Mass spectrometry for the recovered extract revealed the presence of a diverse group of bipolar nature, hydrophobic hydrocarbon chain and charged function group. The majority of these compounds are fatty acids. Based on results of GC–MS, compositional analysis content and Zetasizer, it was proposed that the extracted biosurfactant produced by haloarchaeon Natrialba sp. M6 could be a cationic lipoprotein. The antiviral activity of such biosurfactant was investigated against hepatitis C (HCV) and herpes simplex (HSV1) viruses at its maximum safe doses (20 μg/mL and 8 μg/mL, respectively). Its mode of antiviral action was declared to be primarily via deactivating viral envelopes thus preventing viral entry. Moreover, this biosurfactant inhibited RNA polymerase- and DNA polymerase-mediated viral replication at IC(50) of 2.28 and 4.39 μg/mL, respectively also. Molecular docking studies showed that surfactin resided well and was bound to the specified motif with low and accepted binding energies (ΔG = − 5.629, − 6.997 kcal/mol) respectively. Therefore, such biosurfactant could be presented as a natural safe and effective novel antiviral agent. Nature Publishing Group UK 2022-10-04 /pmc/articles/PMC9531635/ /pubmed/36195643 http://dx.doi.org/10.1038/s41598-022-20091-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hegazy, Ghada E. Abu-Serie, Marwa M. Abou-elela, G. M. Ghozlan, Hanan Sabry, Soraya A. Soliman, Nadia A. Teleb, Mohamed Abdel-Fattah, Yasser R. Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV |
title | Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV |
title_full | Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV |
title_fullStr | Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV |
title_full_unstemmed | Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV |
title_short | Bioprocess development for biosurfactant production by Natrialba sp. M6 with effective direct virucidal and anti-replicative potential against HCV and HSV |
title_sort | bioprocess development for biosurfactant production by natrialba sp. m6 with effective direct virucidal and anti-replicative potential against hcv and hsv |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531635/ https://www.ncbi.nlm.nih.gov/pubmed/36195643 http://dx.doi.org/10.1038/s41598-022-20091-0 |
work_keys_str_mv | AT hegazyghadae bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv AT abuseriemarwam bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv AT abouelelagm bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv AT ghozlanhanan bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv AT sabrysorayaa bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv AT solimannadiaa bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv AT telebmohamed bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv AT abdelfattahyasserr bioprocessdevelopmentforbiosurfactantproductionbynatrialbaspm6witheffectivedirectvirucidalandantireplicativepotentialagainsthcvandhsv |